Document › Details

Proteome Sciences plc. (9/23/10). "Press Release: Protein Biomarker Collaboration with Thermo Fisher Scientific".

	Region	Frankfurt am Main
	Country	Germany
	Organisation	Proteome Sciences R&D GmbH & Co. KG
	Group	Proteome Sciences (Group)
	Organisation 2	Thermo Fisher Scientific Inc. (NYSE: TMO)
	Group	Thermo Fisher (Group)
	Product	TMT® (isobaric tandem mass tag) technology
	Product 2	TSQ Vantage™ triple-stage quadrupole mass spectrometer
	Index term	Proteome Sciences–Thermo Fisher: mass spectrometer, 201009 supply installation LTQ Orbitrap Velos at Frankfurt Lab of Proteome Sciences
	Person	Pike, Ian (Proteome Sciences 201009 COO)

Proteome Sciences (AIM:PRM) is pleased to announce a new additional collaboration with Thermo Fisher Scientific Inc. to deliver innovative products in protein biomarker research and to further develop quantitative proteomic workflows for biomarker discovery and validation. For its role in the collaboration, Proteome Sciences will combine state-of-the-art Thermo Scientific mass spectrometry technology with its integrated PS Biomarker Services workflow incorporating tandem mass tag (TMT®) reagents.

This new collaboration means that Proteome Sciences will now be working with its existing Reagents in the practical application of biomarker technology, opening up new and significant revenue opportunities to both Proteome Sciences and Thermo Fisher.

Full details of the Press Release issued by Thermo Fisher Scientific can be found at www.thermo.com/news and here.

Commenting on the collaboration from the HUPO Conference, Sydney, Dr. Ian Pike, Proteome's Chief Operating Officer stated:

"The Thermo Scientific Orbitrap LTQ Velos mass spectrometer, with its unique combination of HCD and ETD fragmentation, will allow us to extend the scope of proteomic services we offer to customers and extends the scope of future revenues. When using the TSQ™ Vantage in combination with our proprietary TMT tandem mass tag technology for assay development, we can offer the most integrated biomarker discovery, qualification and assay validation workflows in the industry.

We have already successfully used TMT technology to develop mass spec assays for blood biomarkers in Alzheimer's disease and are expanding our coverage for other proprietary biomarkers in cancer and brain damage.

This considerably extends, strengthens and enhances the existing arrangements and license that we have with Thermo Fisher. Access to these resources and our protein biomarker services can be outsourced from our PS Biomarker Services Division in Frankfurt where Proteome has recently installed Thermo Scientific LTQ Orbitrap Velos and TSQ Vantage mass spectrometer systems."

Record changed: 2011-12-04

Follow Us!

Top News

Upcoming Events

Associations

Partners

Proteome Sciences plc. (9/23/10). "Press Release: Protein Biomarker Collaboration with Thermo Fisher Scientific".

More documents for Proteome Sciences (Group)